Results depend heavily on what you eat, how active you are, and your overall health picture
The voice in your head that used to demand a snack at 3 PM goes quiet
Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and increased by 2.5 mg every 4 weeks up to a maintenance dose of 5-15 mg based on tolerability and therapeutic response
Patients here in Westchester County reach for this drip during demanding weeks, after long-haul travel, when a recurring midday slump has quietly become the norm, or simply when they want to show up sharper for the things that matter
AOD 9604 is a modified peptide fragment of human growth hormone (HGH), specifically a stabilized version of amino acids 176191 of the HGH molecule
Decrease dose consideration: Persistent side effects including headaches, fatigue, or injection site reactions, excessive response (extremely rapid weight loss suggesting dose may be higher than needed), cost concerns when lower doses might achieve similar results